Neogenomics Inc (NASDAQ:NEO) Has Seen A Fall Of -56.55% This Year, Is It Still A Better Option Than Others?
In last trading session, Neogenomics Inc (NASDAQ:NEO) saw 1.43 million shares changing hands with its beta currently measuring 1.63. Company’s recent per share price level